Publications

November 2007
Case

Antegren: A Beacon of Hope

By: Joshua D. Margolis, Thomas J. DeLong and Terence Heymann

The CEO of Biogen Idec faces a set of difficult decisions regarding a promising drug for Multiple Sclerosis that is headed for early approval by the FDA. The first in a series focuses on operational decisions triggered by the drive for early approval. Sparks discussion... View Details

Keywords: Demand and Consumers; Leadership; Ethics; Corporate Social Responsibility and Impact; Decision Choices and Conditions; Crisis Management; Health Testing and Trials; Biotechnology Industry; Biotechnology Industry

Educators

June 2004 (Revised May 2005)
Case

Judah Folkman and the War on Cancer

Judah Folkman, professor in the Division of Vascular Biology at Children's Hospital in Boston, is considering how best to advance the research in his lab in an era where biomedical research has gotten more interdisciplinary and collaborative. Specifically, Folkman has... View Details

Keywords: Conflict of Interests; Leadership; Research; Personal Development and Career; Health Care and Treatment; Collaborative Innovation and Invention; Biotechnology Industry; Biotechnology Industry; Boston

September 1995
Case

Ares-Serono

By: Michael Y. Yoshino, Jean-Pierre Jeannet and Carin-Isabel Knoop

Ares Serono, a medium-size Swiss pharmaceutical company, is the global leader in the field of fertility drugs. The company has successfully transformed into one of the very few biotech firms in Europe. The case treats a set of major strategic and organizational... View Details

Keywords: Geographic Location; Globalized Firms and Management; Asset Management; Balance and Stability; Expansion; Digital Platforms; Leadership Development; Health Care and Treatment; Transformation; Family Business; Problems and Challenges; Biotechnology Industry; Biotechnology Industry; Switzerland; Europe

06 Sep 2024
Blog Post

Harvard Business School Announces 2024 Goldsmith Fellows

noted, “I’m excited to learn from other fellows and explore opportunities for collaboration across other systems, including policy, healthcare, and criminal justice.” Keemia Azvine. Keemia, who is pursuing a MS/MBA in Biotechnology Life... View Details

20 Jun 2019
Blog Post

What is the MS/MBA Biotechnology: Life Sciences Program? A Q&A with Bill Anderson, Senior Lecturer on Stem Cell and Regenerative Biology

Why is Harvard launching this program now? The advances in biotechnology over the past decade have been astounding. These new innovations have led to new therapeutics that will involve social, business, and political implications.... View Details

01 Jun 1998
News

Short Takes

inextricably intertwined with institutions that are inherently local," he writes. He intends to test his findings by investigating process innovation in companies entering the semiconductor industry from Europe and Asia. He also plans to conduct a similar study of... View Details

Keywords: Orna Feldman and Caroline Chauncey

17 Oct 2012
Research & Ideas

America Needs a Manufacturing Renaissance

innovation process, but it is not the whole thing. Innovation is about moving the idea from concept to the customer's hands. For some highly complex products (flat-panel displays, PV cells, and biotechnology drugs, to name a few) the... View Details

Keywords: by Gary P. Pisano & Willy C. Shih; Manufacturing

15 Feb 2000
Research & Ideas

The Right Connections

of IPO Team Ties on Investment Bank Affiliation and IPO Success," which examines how individuals' affiliations can affect the formation of alliances at the firm level. To that end, the researchers pinpointed the biotechnology... View Details

Keywords: by Judith A. Ross

01 Jun 2005
News

Marked Managers

assignments. In the 1980s, biotechnology was a fledgling field. The scientists who were making breakthroughs and their venture capitalists needed businesspeople who were entrepreneurial and who could piece together an organization without... View Details

Keywords: Deborah Blagg; Career Imprints; Management of Companies and Enterprises; Management

September 2008 (Revised July 2012)
Case

Khosla Ventures: Biofuels Strategy

By: Joseph B. Lassiter III, William A. Sahlman and Alison Berkley Wagonfeld

By 2008, a number of the firm's early cleantech investments were showing promise, and the companies were starting to need significantly more money to create the massive scale required in the energy sector. As Khosla thought about the hundreds of millions of dollars... View Details

Keywords: Entrepreneurial Marketing; Entrepreneurial Finance; New Product Development; Partnerships; Entrepreneurial Management; Venture Capital; Strategy; Partners and Partnerships; Renewable Energy; Entrepreneurship; Investment Funds; Environmental Sustainability; Product Development; Biotechnology Industry; Biotechnology Industry

Educators

April 1995 (Revised April 1999)
Teaching Note

Aberlyn Capital Management TN

By: Josh Lerner

Teaching Note for (9-294-083). View Details

Keywords: Biotechnology Industry; Biotechnology Industry

09 Apr 2012
Research & Ideas

Who Sways the USDA on GMO Approvals?

Many corporations have gotten good at pulling the levers of government to tilt the odds in their favor, weakening regulations or securing perks, justified or not, to further their business interests. Economists use the term "regulatory capture" to describe... View Details

Keywords: by Michael Blanding; Biotechnology; Biotechnology; Biotechnology

September 2013 (Revised August 2014)
Case

Claritas Genomics

By: Robert F. Higgins and Matthew Preble

Claritas Genomics was formed in January 2013 when BCH spun out its Genetics Diagnostic Lab into a fully commercial entity. Claritas offered over 100 genomic tests to detect a range of conditions, including autism and intellectual disabilities, and was developing new... View Details

Educators

September 2008
Background Note

Background on the Technology of Molecular Diagnostics

By: Regina E. Herzlinger and Jason Sanders

To be used as background reading for the "EXACT Sciences Corp.: Commercializing a Diagnostic Test" and "Diagnostic Genomics" cases, HBS nos. 308-090 and 309-040. View Details

Keywords: Health Testing and Trials; Technology; Biotechnology Industry; Biotechnology Industry